Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults

The Cardiovascular Health Study

Parveen K. Garg, Mary L. Biggs, Joshua Barzilay, Luc Djousse, Calvin H Hirsch, Joachim H. Ix, Jorge R. Kizer, Russell P. Tracy, Anne B. Newman, David S. Siscovick, Kenneth J. Mukamal

Research output: Contribution to journalLetter

Abstract

Carboxymethyl-lysine is an advanced glycation end product that is detectable in the serum. Higher carboxymethyl-lysine levels have been associated with increased risk of coronary heart disease, stroke and cardiovascular mortality. We determined whether high carboxymethyl-lysine levels are also associated with the risk of peripheral artery disease in Cardiovascular Health Study participants who were all aged 65 years and older at baseline. Multivariate Cox proportional hazards models were used to determine the association of baseline carboxymethyl-lysine levels with incident peripheral artery disease in 3267 individuals followed for a median length of 10.0 years. A total of 157 cases of incident peripheral artery disease occurred during follow-up. No significant relationship between carboxymethyl-lysine and risk of peripheral artery disease was found (hazard ratio per standard deviation increment = 1.03; 95% confidence interval = 0.87, 1.23).

Original languageEnglish (US)
JournalDiabetes and Vascular Disease Research
DOIs
StatePublished - Jan 1 2019

Fingerprint

Advanced Glycosylation End Products
Peripheral Arterial Disease
Health
Proportional Hazards Models
Coronary Disease
Myocardial Infarction
N(6)-carboxymethyllysine
Confidence Intervals
Mortality
Serum

Keywords

  • Advanced glycation end products
  • ankle–brachial index
  • inflammation
  • peripheral artery disease

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults : The Cardiovascular Health Study. / Garg, Parveen K.; Biggs, Mary L.; Barzilay, Joshua; Djousse, Luc; Hirsch, Calvin H; Ix, Joachim H.; Kizer, Jorge R.; Tracy, Russell P.; Newman, Anne B.; Siscovick, David S.; Mukamal, Kenneth J.

In: Diabetes and Vascular Disease Research, 01.01.2019.

Research output: Contribution to journalLetter

Garg, Parveen K. ; Biggs, Mary L. ; Barzilay, Joshua ; Djousse, Luc ; Hirsch, Calvin H ; Ix, Joachim H. ; Kizer, Jorge R. ; Tracy, Russell P. ; Newman, Anne B. ; Siscovick, David S. ; Mukamal, Kenneth J. / Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults : The Cardiovascular Health Study. In: Diabetes and Vascular Disease Research. 2019.
@article{e02aecea3c314940a5129bd52559587f,
title = "Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults: The Cardiovascular Health Study",
abstract = "Carboxymethyl-lysine is an advanced glycation end product that is detectable in the serum. Higher carboxymethyl-lysine levels have been associated with increased risk of coronary heart disease, stroke and cardiovascular mortality. We determined whether high carboxymethyl-lysine levels are also associated with the risk of peripheral artery disease in Cardiovascular Health Study participants who were all aged 65 years and older at baseline. Multivariate Cox proportional hazards models were used to determine the association of baseline carboxymethyl-lysine levels with incident peripheral artery disease in 3267 individuals followed for a median length of 10.0 years. A total of 157 cases of incident peripheral artery disease occurred during follow-up. No significant relationship between carboxymethyl-lysine and risk of peripheral artery disease was found (hazard ratio per standard deviation increment = 1.03; 95{\%} confidence interval = 0.87, 1.23).",
keywords = "Advanced glycation end products, ankle–brachial index, inflammation, peripheral artery disease",
author = "Garg, {Parveen K.} and Biggs, {Mary L.} and Joshua Barzilay and Luc Djousse and Hirsch, {Calvin H} and Ix, {Joachim H.} and Kizer, {Jorge R.} and Tracy, {Russell P.} and Newman, {Anne B.} and Siscovick, {David S.} and Mukamal, {Kenneth J.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1479164119847481",
language = "English (US)",
journal = "Diabetes and Vascular Disease Research",
issn = "1479-1641",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults

T2 - The Cardiovascular Health Study

AU - Garg, Parveen K.

AU - Biggs, Mary L.

AU - Barzilay, Joshua

AU - Djousse, Luc

AU - Hirsch, Calvin H

AU - Ix, Joachim H.

AU - Kizer, Jorge R.

AU - Tracy, Russell P.

AU - Newman, Anne B.

AU - Siscovick, David S.

AU - Mukamal, Kenneth J.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Carboxymethyl-lysine is an advanced glycation end product that is detectable in the serum. Higher carboxymethyl-lysine levels have been associated with increased risk of coronary heart disease, stroke and cardiovascular mortality. We determined whether high carboxymethyl-lysine levels are also associated with the risk of peripheral artery disease in Cardiovascular Health Study participants who were all aged 65 years and older at baseline. Multivariate Cox proportional hazards models were used to determine the association of baseline carboxymethyl-lysine levels with incident peripheral artery disease in 3267 individuals followed for a median length of 10.0 years. A total of 157 cases of incident peripheral artery disease occurred during follow-up. No significant relationship between carboxymethyl-lysine and risk of peripheral artery disease was found (hazard ratio per standard deviation increment = 1.03; 95% confidence interval = 0.87, 1.23).

AB - Carboxymethyl-lysine is an advanced glycation end product that is detectable in the serum. Higher carboxymethyl-lysine levels have been associated with increased risk of coronary heart disease, stroke and cardiovascular mortality. We determined whether high carboxymethyl-lysine levels are also associated with the risk of peripheral artery disease in Cardiovascular Health Study participants who were all aged 65 years and older at baseline. Multivariate Cox proportional hazards models were used to determine the association of baseline carboxymethyl-lysine levels with incident peripheral artery disease in 3267 individuals followed for a median length of 10.0 years. A total of 157 cases of incident peripheral artery disease occurred during follow-up. No significant relationship between carboxymethyl-lysine and risk of peripheral artery disease was found (hazard ratio per standard deviation increment = 1.03; 95% confidence interval = 0.87, 1.23).

KW - Advanced glycation end products

KW - ankle–brachial index

KW - inflammation

KW - peripheral artery disease

UR - http://www.scopus.com/inward/record.url?scp=85065659774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065659774&partnerID=8YFLogxK

U2 - 10.1177/1479164119847481

DO - 10.1177/1479164119847481

M3 - Letter

JO - Diabetes and Vascular Disease Research

JF - Diabetes and Vascular Disease Research

SN - 1479-1641

ER -